Skip to content
Clinical Trials – home

Marfan's syndrome Diagnostics

1 / 1 trials open to patients1 country

In short

Understanding when and how to diagnose Marfan syndrome is crucial for protecting your health and preventing serious complications. This genetic condition affects connective tissue throughout the body, and early detection through the right tests can make a significant difference in managing the condition and maintaining quality of life.

Key points

  • Early diagnosis is critical because Marfan syndrome can affect your aorta in ways that become life-threatening without proper monitoring and treatment.
  • No single test can diagnose Marfan syndrome – doctors piece together information from physical exams, family history, heart imaging, eye exams, and genetic testing.
  • About 75% of people with Marfan syndrome inherited it from a parent, but 25% are the first in their family to have the condition due to a spontaneous genetic mutation.
  • The revised Ghent criteria place special emphasis on two major features: enlargement of the aortic root and dislocation of the eye lens.
  • Regular echocardiograms are essential after diagnosis because the aorta can gradually enlarge over time, requiring ongoing monitoring to prevent serious complications.
  • Many features of Marfan syndrome don't become obvious until the teenage years or young adulthood, even though the condition is present from birth.
  • With proper diagnosis, treatment, and monitoring, people with Marfan syndrome can now expect a life expectancy close to that of the general population.
  • Clinical trials for Marfan syndrome require detailed diagnostic testing to establish baseline measurements and ensure participant safety throughout the research study.

Introduction: Who Should Seek Diagnostic Testing

If you notice certain physical traits in yourself or your child, it may be time to consider getting tested for Marfan syndrome. People who are unusually tall and thin, with arms, legs, fingers, and toes that seem disproportionately long compared to the rest of their body, should talk to their doctor about evaluation. This condition can be difficult to spot early because many signs don't become obvious until the teenage years or young adulthood, though the syndrome is present from birth.

You should also seek diagnostic testing if you have a family history of Marfan syndrome. Because this condition is inherited in about three out of four cases, children of a parent with the syndrome have a 50 percent chance of inheriting it themselves. Even if no one in your family has been diagnosed, spontaneous genetic changes can occur, meaning you could be the first person in your family to develop the condition. In fact, about one in four people with Marfan syndrome has no family history of the disorder.

Vision problems offer another important reason to consider testing. If you or your child experiences unexplained eye pain, sudden vision changes, severe nearsightedness, or problems with the position of the eye lens, these could be warning signs. Similarly, heart-related symptoms shouldn't be ignored. A heartbeat that feels like it's racing, pounding too hard, or skipping beats may indicate problems with the heart or blood vessels that are common in Marfan syndrome.

Parents should be particularly alert if their child shows multiple physical features associated with the condition. These include a long, narrow face, crowded teeth, a curved spine, a chest that either sinks inward or protrudes outward, flat feet, or joints that are unusually flexible and prone to dislocation. Sometimes unexpected stretch marks that appear without weight changes can be another clue. Because Marfan syndrome can affect so many parts of the body, recognizing these patterns is important for seeking timely evaluation.

Classic Diagnostic Methods

Diagnosing Marfan syndrome can be challenging for doctors because many connective tissue disorders share similar features, and even within the same family, the signs and symptoms can vary dramatically in both their appearance and severity. Making an accurate diagnosis requires piecing together information from several different sources and tests, rather than relying on any single examination.

Physical Examination and Medical History

The diagnostic process typically begins with a thorough physical examination. Your doctor will carefully measure various parts of your body and look for the characteristic features of Marfan syndrome. They'll examine the length of your arms, legs, fingers, and toes, and check for distinctive physical traits like a long, narrow face, crowded teeth, or chest deformities. The physician may want to measure your arm span to see if it's disproportionate to your height, which is common in people with this condition.

During this examination, doctors often look for specific hand signs that can suggest Marfan syndrome. One sign involves making a fist to see if your thumb extends far beyond the edge of your hand. Another involves wrapping your thumb and fingers around your opposite wrist to check if they overlap more than usual. The doctor will also check your joints to see if they're unusually flexible or prone to dislocation, examine your spine for curvature, and look at your chest to see if it's sunken or protruding.

Gathering a detailed family history is equally crucial. Your doctor will ask questions about relatives who may have had the condition, even if they were never formally diagnosed. They'll want to know about any family members who died young from heart problems, had unusual body proportions, or experienced unexplained vision problems. This family history helps establish whether the condition runs in your family or if you're experiencing a spontaneous genetic mutation.

Heart Testing

Because Marfan syndrome commonly affects the heart and blood vessels, heart testing is one of the most important parts of the diagnostic process. The primary test used is an echocardiogram, which uses sound waves to create real-time moving images of your heart. This painless test allows doctors to examine your heart valves and measure the size of your aorta, looking for enlargement or bulging that could indicate Marfan syndrome.

The echocardiogram is particularly useful because the two main features doctors look for in Marfan syndrome are widening of the aorta near the heart valve (called aortic root aneurysm) and a dislocated eye lens. If either of these features is present along with other signs, it strengthens the diagnosis. Other heart-imaging tests may also be used, including computerized tomography (CT) scans and magnetic resonance imaging (MRI), which provide detailed pictures of the heart and blood vessels from different angles.

If you're diagnosed with Marfan syndrome, regular imaging tests become part of your ongoing care to monitor the size and condition of your aorta over time. These follow-up tests help your medical team catch any changes early, before they become dangerous.

Eye Examinations

Comprehensive eye examinations are another critical component of diagnosing Marfan syndrome. An ophthalmologist, a doctor who specializes in eye conditions, will perform specialized tests to look for problems that are common with this disorder. One key test is the slit-lamp exam, which checks for a dislocated lens, cataracts, or a detached retina. For this exam, your eyes will need to be completely dilated with special drops so the doctor can see the internal structures clearly.

The doctor will also measure the pressure inside your eyeball using a tool that gently touches your eye after numbing drops are applied. This test checks for glaucoma, an eye condition where increased pressure can damage the optic nerve. People with Marfan syndrome have a higher risk of developing glaucoma and other eye complications, including severe nearsightedness (myopia) and astigmatism.

A dislocated or shifted lens is one of the hallmark features of Marfan syndrome. When the lens of your eye falls into an abnormal position, it can cause vision problems and eye pain. Finding this during examination, especially when combined with other features of the syndrome, provides strong evidence for the diagnosis.

Genetic Testing

Genetic testing is often used to confirm the diagnosis of Marfan syndrome. This type of testing looks for changes (mutations) in the FBN1 gene, which provides instructions for making a protein called fibrillin. Fibrillin is a crucial component of elastic fibers in connective tissue, and mutations in this gene cause the weakened connective tissue characteristic of Marfan syndrome.

The genetic test typically requires a blood sample. If a Marfan mutation is found in the FBN1 gene, it confirms the diagnosis. This information can then be used to test other family members to see if they're also affected, even if they don't yet show obvious symptoms. Knowing who carries the mutation allows for early monitoring and preventive care.

However, it's important to understand that not finding a mutation doesn't necessarily mean you don't have Marfan syndrome. Genetic testing isn't perfect, and sometimes mutations can be missed, or the changes in the gene might be difficult to interpret. That's why doctors don't rely on genetic testing alone but consider it as one piece of the diagnostic puzzle alongside physical features, family history, and imaging results.

Revised Ghent Criteria

Doctors use a specific set of guidelines called the revised Ghent criteria to make a diagnosis of Marfan syndrome. Updated in 2010, these criteria place more weight on certain key features: enlargement of the aortic root, dislocated eye lens, mutations in the FBN1 gene, and family history of the condition. A scoring system has been developed for features affecting other body systems, with a maximum score of 20 points. A score of 7 or higher indicates positive systemic involvement and supports the diagnosis.

The combination of different findings determines whether a diagnosis can be made. For example, if you have aortic root enlargement and a family history of Marfan syndrome, that combination may be sufficient. Or if you have a dislocated lens and a known FBN1 mutation, that might confirm the diagnosis. In some cases, a person may have some features of Marfan syndrome but not enough to meet the full diagnostic criteria.

Additional Diagnostic Tests

Depending on your symptoms and the initial findings, your doctor may recommend additional tests. Skeletal evaluations might include X-rays to check for spine curvature (scoliosis), chest deformities, or changes in bone structure. These imaging tests help document the extent to which the skeletal system is affected.

Some people with Marfan syndrome experience breathing difficulties, so lung function tests may be performed. These tests measure how well your lungs work and can detect problems like asthma or increased risk for a collapsed lung (pneumothorax), which occurs more frequently in people with this condition.

Because Marfan syndrome can affect tissues throughout the body, you may need to see multiple specialists as part of the diagnostic process. This team approach ensures that every aspect of the condition is properly evaluated. The specialists might include a geneticist who understands inherited disorders, a cardiologist for heart issues, an ophthalmologist for eye problems, and an orthopedic surgeon for bone and joint concerns.

Diagnostics for Clinical Trial Qualification

When considering participation in clinical trials for Marfan syndrome, additional diagnostic tests and criteria come into play. Clinical trials are research studies that test new treatments or ways of managing the condition, and they have specific requirements for who can participate. The qualification process ensures that the study participants are appropriate for the research being conducted and that results will be meaningful and safe.

For clinical trial enrollment, you'll typically need a confirmed diagnosis of Marfan syndrome based on the revised Ghent criteria. This means having documentation from your medical team that clearly demonstrates you meet the established diagnostic standards through physical examination, imaging tests, family history, and possibly genetic testing. Trials may require recent testing results, often within the past year, to ensure your current medical status is accurately known.

Baseline imaging of the heart and aorta is almost always required for clinical trials involving Marfan syndrome because cardiovascular complications are the most serious aspect of the condition. An echocardiogram or other imaging test like MRI or CT scan will be used to measure the exact size of your aorta and assess the condition of your heart valves. These baseline measurements are crucial because they provide a starting point to compare against future images, allowing researchers to see whether a treatment is slowing, stopping, or reversing aortic enlargement.

Many clinical trials have specific inclusion and exclusion criteria based on the size of the aorta. For example, a trial might only accept participants whose aorta has dilated to a certain size but hasn't yet reached the point where surgery is immediately necessary. This ensures the study can properly test whether a medication or intervention helps prevent further enlargement in people at particular stages of the disease.

Genetic testing results may also be required for clinical trial participation. Some trials specifically study people with confirmed FBN1 mutations, while others might be open to people diagnosed clinically even without genetic confirmation. If you're interested in participating in a clinical trial, having your genetic test results readily available can help determine your eligibility more quickly.

Before enrolling in a clinical trial, you'll undergo comprehensive medical screening to ensure the trial is safe for you and that you meet all the necessary criteria. This screening typically includes a complete physical examination, detailed medical history, blood tests to check your overall health and organ function, and sometimes additional specialized tests depending on what the trial is studying. The goal is to establish your baseline health status and identify any other medical conditions that might affect your participation or safety.

Eye examinations may also be part of clinical trial qualification, particularly for studies examining treatments that could affect multiple body systems. Documenting the status of your eyes at the beginning of the trial helps researchers monitor whether any changes occur during the study period.

Throughout the clinical trial, you'll receive ongoing diagnostic monitoring. This typically includes repeated imaging tests at regular intervals to track any changes in your aorta and heart. Blood tests may be done periodically to check for any effects of the treatment being studied. Physical examinations and symptom assessments help researchers understand how the treatment affects quality of life and overall health. All of these diagnostic measures work together to provide a comprehensive picture of how the experimental treatment is working and whether it's safe.

Prognosis and Survival Rate

Prognosis

The outlook for people with Marfan syndrome has improved dramatically over the past few decades thanks to advances in medical care, surgical techniques, and early diagnosis. With proper treatment and close monitoring, many people with Marfan syndrome can live long and productive lives. The prognosis depends largely on which parts of the body are affected and how severely, as well as how early the condition is diagnosed and treated. The most serious complications involve the heart and blood vessels, particularly the aorta. Without treatment, problems with the aorta can become life-threatening through rupture or dissection (tearing of the blood vessel wall). However, with regular monitoring and appropriate medical or surgical intervention, these catastrophic events can often be prevented. Close follow-up with your medical team is essential for maintaining the best possible prognosis.

Survival rate

Life expectancy for people with Marfan syndrome has increased significantly with modern medical management. Currently, people with Marfan syndrome who receive proper care have a life expectancy that approaches that of the general population. Just three decades ago, survival was considerably shorter, but advances in treatment have made a tremendous difference. Medical therapies that reduce stress on the aorta, combined with improved surgical techniques for repairing damaged blood vessels and heart valves, have been particularly important in extending lifespan. Regular monitoring allows doctors to intervene before problems become critical, which has dramatically improved outcomes. People with Marfan syndrome can now expect to live into their 60s, 70s, and beyond when they follow recommended treatment plans and maintain regular contact with their healthcare providers.

Did you know?

  1. Some historians believe Abraham Lincoln may have had Marfan syndrome based on his unusually tall, thin body build and long limbs, though this can never be confirmed.
  2. The condition is named after Antoine Marfan, a French pediatrician who first described the syndrome in 1896 after observing a young girl with unusually long, thin fingers and limbs.
  3. Despite affecting connective tissue throughout the body, Marfan syndrome does not affect intelligence or cognitive function in any way.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Marfan's syndrome

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Valsartan
  • Sponsor:Medical University Of Gdansk
See all 1 trials →filters applied: condition = Marfan's syndrome

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).